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Abstract: This article describes Anti-Persoonsmijnen Ontmijnende Product Ontwikkeling (APOPO)
recent use of specially trained African giant pouched rats as detectors of pulmonary tuberculosis in
people living in Tanzania. It summarizes the achievements and challenges encountered over the years
and outlines future prospects. Since 2008, second-line screening by the rats has identified more than
2000 tuberculosis-positive patients who were missed by microscopy at Direct Observation of
Treatment – Short Course centres in Tanzania.  Moreover, data that are reviewed herein have been
collected with respect to the rats’ sensitivity and specificity in detecting tuberculosis. Findings
strongly suggest that scent-detecting rats offer a quick and practical tool for detecting pulmonary
tuberculosis and within the year APOPO’s tuberculosis-detection project will be extended to
Mozambique.  As part of its local capacity building effort, APOPO hires and trains Tanzanians to play
many important roles in its TB detection project and provides research and training opportunities for
Tanzanian students.
______________________________________________________________________________
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Introduction
Anti-Persoonsmijnen Ontmijnende Product Ontwikkeling (in English, Anti-Personnel
Landmines Detection Product Development), characteristically referred to by its acronym,
APOPO, is a Belgian non-profit humanitarian organization that started its preliminary
research on the sniffing capacity of African giant pouched rats (Cricetomys gambianus) in
Antwerp in 1997. In 2000, APOPO signed a partnership agreement with Sokoine University
of Agriculture (SUA), Tanzania, Antwerp University (AU), and the Tanzanian Peoples
Defence Force (TPDF) which let it build its headquarters, as well as its training and research
facilities, on the premises of SUA under the auspices of the Pest Management Centre.
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Initially, rats were collected from the outskirts of Morogoro municipality and from the
slopes of Uluguru Mountains using Havahart® traps (Havarhart, Woodstream Corp., PA,
USA) and then transferred to breeding kennels at the project site. The breeding kennels were
constructed to imitate the rats' natural environment and now provide a continuous supply
of rats for the project.
Cricetomys for Landmine Detection
African giant pouched rats, which are native to sub-Saharan Africa, are nocturnal and
omnivorous members of the Nesomyidae family within the Muroidea superfamily. They are
large colony-dwelling rodents, with adult body lengths of 25-45cm and tail lengths of 35-
45cm. Adult females typically weigh 1-1.5kg. Males are somewhat larger. Cricetomys can live
up to eight years in captivity. At four weeks of age, APOPO's rats are weaned and thereafter
are housed in pairs in cages with unlimited access to water and a nest box. The rats are fed a
varied diet of fruits, vegetables, grains, and commercial rodent chow. During weekdays they
receive the majority of their food during training sessions so that they are mildly food-
deprived during training and testing. A veterinarian, who provides health care as needed,
regularly examines the rats.
From four weeks to approximately six weeks of age the rats are handled three times
a day by trainers and other people, who expose them to a wide variety of objects, sights,
sounds, and smells and hand-feed them preferred foods such as bananas and peanuts. These
experiences constitute what is often termed “environmental enrichment,” which is known to
improve several aspects of the neurochemistry and behaviour of domestic laboratory rats
(Rattus norvegicus), including their ability to learn and to remember  (Hutchinson et al., 2005;
Nithianantharajah & Hannan, 2005; Van Praag et al., 2000).
Initially, APOPO focused on training rats to detect landmines. Over time, successful
training procedures were devised and Cricetomys currently are being used as accredited
mine detection animals in Mozambique, where APOPO's team has cleared more than 2
million square meters of land. These training procedures and the rat's performance in
operational demining are described elsewhere (Poling et al., 2010a, 2010b, 2010c, 2011b).
Lessons learned in developing effective landmine-detection procedures were put to
good use in training the rats to detect the presence of Mycobacterium tuberculosis, the
microorganism that causes tuberculosis (TB), in human sputum samples and to evaluate
their ability to do so. This work was possible due to a 2004 partnership agreement between
APOPO, SUA, AU, the Tanzanian National Institute of Medical Research (NIMR), and the
Tanzanian National Tuberculosis and Leprosy Programme (NTLP), which jointly committed
to developing a scent-detection technology for diagnosing human TB. Their goal was to
develop a quick, inexpensive, and accurate tool for diagnosing pulmonary tuberculosis to
benefit people living in resource poor areas in sub-Saharan Africa and around the world.
Preliminary Investigations
Initially, a pilot study was conducted to determine the resistance of African giant pouched
rats to TB by putting them in a specially designed cage that was placed in a biosafety cabinet
and exposing the rats to aerosols from live M. tuberculosis broth. Eight rats (four adults and
four young of both sexes) were used in this investigation. Four test rats received Bacilli’s
Calmette-Guerin (BCG) vaccinations while the remaining four served as controls and were
not vaccinated. Both groups were inoculated over an 8-h period by subjecting them to an
aerosol containing 106 to 108 CFU/ml of M. bovis and M. tuberculosis. After an eight-week
observation period these animals and four additional rats recently captured from the wild
were euthanatized. Specimens from test, control, and wild rats were examined for
pathological and molecular evidence of mycobacterial infection. No lesions or traces of
mycobacteria (by PCR) were found in samples obtained from the test, control, or wild rats.
These data suggested that Cricetomys are resistant to mycobacterial infection and could be
safely used as TB-detection animals.
In the second stage of this preliminary investigation, five rats were selected and
vaccinated with BCG. All of them were subjected to odour discrimination training for a
period of eight weeks using inactivated culture isolates in a broth as the training stimulus.
After this period they were split into two groups.  Three rats were further trained to detect
mycobacteria culture isolates and two rats were trained to detect M. tuberculosis in human
sputum samples. The culture isolates were grown and processed at the Microbiology
Laboratory of the Faculty of Veterinary Medicine at SUA and sputum samples were
collected from Direct Observation of Treatment-Short Course (DOTS) centres at the
Morogoro Regional Hospital and at the Muhimbili National Hospital in Dar es Salaam. After
four weeks of training, all five rats were able to indicate consistently on the target TB odour
from the culture isolates as well as from the sputum samples. They did so by pausing
reliably at holes above pots containing known TB-positive samples and not pausing above
holes containing known TB-negative samples. They were trained to respond in this way by
consistently reinforcing (rewarding) with food progressively longer pauses above TB-
positive samples and never reinforcing pauses above TB-negative samples.  Such training is
technically described as “operant discrimination training” and is the basis of all scent
detection applications with animals, including the use of dogs and pouched rats to detect
explosives.
Proof of Principle Study
Although the preliminary study suggested the rats are resistant to TB, a decision was made
to inactivate microbes in the sputum samples so as to protect personnel and the rats from all
possible infectious agents.  For this proof of principle study, about 300 sputum sample sets
were collected per week from selected DOTS centres in Dar es Salaam and Morogoro, using
World Health Organization (WHO) recommended sputum containers (wide-mouthed
container made of clear thin plastic that were disposable, unbreakable, and leak proof). All
the samples were already examined by Ziehl-Neelsen (ZN) smear microscopy at the DOTS
centres and stored in a freezer until they were collected and shipped to APOPO’s facility in
Morogoro. Each sample came from the DOTS centre with information about the sex, age,
and identification number of the patient who produced it and the sample’s ZN microscopy
status (i.e., TB-positive or TB-negative).
One ml of each sputum sample was aseptically set aside for culturing and after the
required sample processing procedure it was inoculated on solid Löwenstein-Jensen
medium, incubated at 37°C and monitored for six weeks. Smears were prepared for
microscopic examination, ZN, from the remaining portion of the sputum, at APOPO’s
laboratory so that DOTS results could be confirmed. Sterile phosphate-buffered saline (PBS,
5 ml) was added to the remaining portion of the sputum sample, which was heat-inactivated
at 90°C in a water bath for 30 min (Doig et al. 2002). All samples were then frozen at –20°C
until the day of evaluation by the rats. During evaluation, sputum samples were presented
to individual rats in a long metal and plastic cage with 10 holes equally spaced along the
centreline of the floor. A sputum sample contained in a pot was placed below each hole and
the rat’s response at each hole was recorded. Pausing for at least five seconds was recorded
as an indication that the sample contained TB, whereas pausing for a shorter time was
recorded as an indication that the sample did not contain TB.
Sixteen rats evaluated a total of 2,597 samples (345 were smear-positive and 2,252
smear-negative at the DOTS centres) over a period of 35 days. The same sets of samples
were presented twice to all rats. The average daily results for the rats as a group ranged
between 72.4 and 99.5% true-positive and 0.6 and 8.1% false-positive when DOTS-centre
evaluations were used as the reference standard. Average scores for all the rats during the
entire 35-day trial were 87.8% true-positive and 4.1% false-positive.  The true-positive level
defines the sensitivity of a diagnostic test and 1 - the false-positive level defines its
specificity. Between the 21st and 32nd days (inclusive), blind samples (i.e., samples for which
the results of microscopy were not revealed to the rat handlers) were included in the daily
sample set. The rats were not rewarded when they indicated on these blind samples. The
true-positive rate for the entire group varied between 82.3 and 100% on the blind positive
samples, with an overall average score of 93.1%. During the 12 days of blind testing, the rats
consistently identified seven DOTS-negative samples as TB-positive. A second ZN analysis
at APOPO’s laboratory confirmed that the rats' evaluation of these samples was correct.
Another series of blinded tests was performed on 7 consecutive days by two rats on a
total of 819 sputum samples, of which 67 were confirmed positive and 752 were confirmed
negative by culture. The cumulative results for the two rats revealed a sensitivity of 86.5%
and a specificity of 89.1%. The average scores and false-positive results per rat were
respectively 73.1% and 6.7%, while the cumulative scores for both rats were respectively
86.5% and 10.9%.  This study clearly demonstrated the potential usefulness of African giant
pouched rats as TB detectors and the publication describing it (Weetjens et al. 2009a) was the
first report of using animals in general, and rats in particular, for TB detection.
Second-line Screening
The promising results of the proof of principle study encouraged members of APOPO’s
research team to evaluate the possibility of using Cricetomys for second-line screening of
sputum samples previously evaluated by microscopy at the DOTS centres. The purpose of
this project was, first, to improve new-case detections and thereby save lives and, second, to
evaluate the rats performance with respect to their potential for use in first-line screening.
Although sputum-smear microscopy characteristically has excellent specificity and is
commonly used in resource poor countries in sub-Saharan Africa and elsewhere, the
method’s sensitivity varies greatly and is often relatively low (Dye et al., 2005; Steingart et al.,
2006). If second-line screening by APOPO’s rats detects a significant number of cases of TB
missed by microscopy, then combining the two techniques could be of substantial clinical
benefit.  Three published studies have evaluated this possibility (Weetjens et al. 2009b;
Poling et al. 2010; Mahoney et al. 2011).
In the first, the rats screened sputum samples collected from 15,041 patients from
four DOTS centres in Dar es Salaam in the period January 2008 to May 2009 and found 577
additional cases beyond the 1,838 detected at the centres, resulting in a 31.4% increase in
case detection (Weetjens et al. 2009b). Similarly, screening of samples collected from 10,523
patients who visited seven DOTS centres in 2009 revealed an additional 620 cases beyond
the 1403 cases found at the centres, i.e. a 44% increase in detection (Poling et al., 2010).
Likewise, samples collected from 12,329 patients have been screened by the rats in the
period January to December 2010 resulting in 716 new cases over the 1671 identified at the
centres, which is a 42.8% increase in new-case detection (Mahoney et al., 2011).  These data
provide substantial evidence that Cricetomys are of clinical value as second-line screens used
in combination with first-line screening by smear microscopy.  To evaluate further the value
of pouched rats in this context, rats and personnel from APOPO will soon begin a second
second-line screening project in Maputo, Mozambique. A major goal of APOPO and its
partners is to expand the use of TB-detection rats as widely as possible in the interest of
reducing human suffering and saving lives.
Improving Sample Processing
One of the advantages of using African giant pouched rats as TB detectors is their speed in
analyzing sputum samples. As described elsewhere (Weetjens et al., 2009; Poling et al., 2010),
a single rat can process many samples per day, which allows multiple rats to evaluate each
sample and offers the possibility of a quick and inexpensive diagnostic tool. In our work to
date, the time required for technicians to prepare samples, not the time required for rats to
analyze them, limited the number of samples that can be processed.  Sample preparation
basically involves addition of phosphate-buffered saline and heat-inactivation using an
autoclave. Developing alternative methods for preparing and presenting samples could
dramatically improve APOPO’s TB-diagnostic product.
One possible strategy to reduce the work and time associated with sample
processing is to have the rats evaluate microscope slides, which are always prepared in
smear microscopy. Data recently collected demonstrate that the rats can detect the presence
of TB on prepared slides, but their accuracy in doing so was substantially lower than when
they evaluated sputum presented in pots (Mahoney et al., 2011b). Although the possibility of
using slides operationally has not been dismissed entirely, alternative strategies for sample
preparation are currently being evaluated. One is using Virkon® S (a new formulation of the
oxidant-based chemical disinfectant Virkon,® produced by E. I. DuPont de Nemours and
Company, Wilmington, DE, USA), rather than autoclaving, to inactivate samples. If Virkon®
S kills infectious microorganisms with a brief contact time and does not affect the rats’
ability to detect the presence of TB; it will be used as the inactivation agent instead of the
phosphate-buffered saline addition and heat-inactivation process currently in use.
Improving Rats’ Detection when Few Bacilli are Present
As described previously, APOPO’s rats are performing an operant discrimination when they
detect TB. Because historically they have been reinforced only when they emit an
identification response (pause for five seconds) at a sample containing M. tuberculosis, they
learn to emit the identification response only when they encounter the odour characteristic
of the bacillus. There is a large body of scientific literature on discrimination learning,
showing that the intensity of the stimuli (e.g., concentration of bacilli in our case) which the
animals are initially trained to identify, affects their subsequent performance (Catania, 1999;
Chance, 2003). We observed this phenomenon when rats were trained to detect 2,4,6-
trinitrotoluene (TNT), which is the main explosive charge in the vast majority of landmines.
Those rats trained and reinforced to detect a low concentration of TNT (10ng/L) easily
detected different concentrations of TNT (10 and 100 ng/L); whereas rats trained only to
detect a high concentration did not detect TNT 10ng/L reliably. A similar phenomenon was
observed when we examined routine training data for the month of August 2009, during
which TB-detection rats were trained on sputum samples graded as AFB (scanty), +1, +2 and
+3 at the DOTS centres (Table 1).
Table 1: Sensitivity of rats on sputum samples with different concentration of bacilli
Rat name Sensitivity (% of samples identified as TB-positive by the rat)
AFB (scanty) +1 +2 +3
Allen 12.5 82.4 97.2 90
Brown 70 84.3 93.8 100
Bruce 50 75.9 93.8 95.5
Laila 50 82.2 98 100
Onur 46.2 85.8 100 90.9
Patron 50 79.5 92.9 90.9
Queen 43.8 72.2 100 100
Richard 54.5 79.9 90.3 100
Each of the eight rats examined detected a substantially lower percentage of AFB samples
than of higher-concentration samples. We believe the main reason for this is that very few
low concentration (AFB or scanty) samples are detected at the DOTS centres, therefore our
rats are primarily trained to detect high-concentration samples. Such training may well limit
their tendency to emit identification responses to low-intensity stimuli that is, to samples
containing low levels of M. tuberculosis, even if the rats can reliably detect the odour of those
bacilli.
Because microscopy is especially likely to misidentify (i.e., designate as TB-negative)
smears that properly should be considered AFB (Fujika, 2005), when the rats are used in
second-line screening it is especially important that they reliably emit an identification
response to such low-intensity samples. It is, of course, also important that they consistently
identify high-concentration samples. A logical strategy to pursue in increasing the likelihood
that rats will reliably identify both low- and high-concentration samples is to train them only
with low-concentration samples. Such training is currently underway and it is anticipated
that rats specifically trained to identify low-concentration samples will be more sensitive in
identifying low-concentration sputum samples than rats not given such training, and
similarly sensitive in identifying higher-concentration samples.
Improving Confirmatory Methods
From the beginning, the actual status of sputum samples identified as TB-negative by DOTS
centres’ microscopy and TB-positive by APOPO’s rats has been determined by a second
microscopy (ZN or more recently fluorescent) performed in APOPO’s laboratory.  Although
fluorescent microscopy often is more sensitive than ZN light microscopy, neither have
consistently high sensitivity (Steingart, 2006). Therefore, a rat-positive sample found not to
contain M. tuberculosis by two microscopies may not be a true negative, especially if few
bacilli are present.  From a scientific perspective, the result is an inflated false-positive rate
for the rats and from a clinical perspective the result is a failure to detect and treat some
cases of TB correctly identified by the rats.
To deal with these issues, we are exploring the possibility of using an automated
polymerase chain reaction (PCR) analysis performed by a Cepheid GeneXpert (Xpert
MTB/RIF, Sunnyvale, CA) as the final confirmation of sample status. Although the
GeneXpert has high sensitivity and specificity (Boeme et al., 2010), it is rather slow.
Moreover, each test is relatively expensive (c. US$20).  Using the GeneXpert only to evaluate
microscopy-negative, rat-positive samples may be viable in both research and operational
contexts, however, because relatively few such samples appear, which minimizes overall
cost and processing time.
With the exception of limited data for two rats in the study by Weetjens et al. (2009a),
the performance of APOPO’s rats has been determined by comparison to the results of
microscopy, which characteristically has high specificity but relatively low (and variable)
sensitivity (Dye et al., 2005; Steingart et al., 2006). The low sensitivity of smear microscopy
makes it a poor reference standard from a scientific perspective although it is imperative to
compare the rats’ performance to that of microscopy, because the goal is to use them as an
adjunct to (in second-line screening) or alterative to (in first-line screening) that method.
We have recently completed a study (Mahoney et al., 2012a) in which the results of
evaluation by 10 rats and by microscopy conducted at DOTS centres were compared to the
results of culturing and PCR analysis of 910 sputum samples. In this research, an M.Sc.
student in Applied Microbiology at the Faculty of Veterinary Medicine of SUA and his
colleagues compared rats’ evaluations with the results of ZN microscopy, culture on solid
Lowenstein-Jensen (LJ) media whose isolates were checked by ZN microscopy, and PCR
analysis of the culture isolates. Samples collected from 456 patients were analyzed. When
three rats were randomly assigned to form a group, and when a sample was considered as
TB-positive if 2 of the 3 rats in the group emitted an indicator response to that sample, an
average sensitivity of 72% and specificity of 94% was achieved with the PCR results as the
reference standard. When also compared to PCR results, the sensitivity of DOTS microscopy
was 48% and the specificity was 98%. Moreover, the rats identified 23 TB-positive cases that
were not identified by microscopy, that is, they increased the case detection rate by 48.9%.
These results provide further evidence that pouched rats are a valuable adjunct to, and may
be a viable substitute for, sputum smear microscopy as a TB diagnostic in resource poor
countries.
Although culturing (often followed by PCR analysis) is a well-accepted reference
standard for TB detection, it can be difficult to perform accurately, especially in operational
settings in resource poor area, and should not be viewed as an infallible index of the
presence or absence of M. tuberculosis in tested patients (Kivihya-Ndugga et al., 2004;
Mendoza et al., 1993; Parvez et al., 2003). APOPO’s research team and its partners have
successfully cultured M. tuberculosis, but it is a difficult and expensive task in our
operational setting and not feasible as a consistent reference standard. Moreover, it may not
be as sensitive as one would hope.
For example, we recently used a GeneXpert to analyze 60 sputum samples that were
negative by microscopy as well as culture but indicated as positive by multiple rats.
Eighteen of them (30%) were found to be positive for M. tuberculosis. We also analyzed 100
samples that were negative by all techniques including the rats and found only 8% of them
positive by Xpert MTB/RIF (Unpublished result). This result clearly suggests that under the
conditions where APOPO operates, the automated molecular technique is more sensitive
than other available methods. As noted previously, however, the GeneXpert (like other
molecular techniques) is too expensive for routine screening in resource poor countries.
Moreover, some experts argue that every TB diagnostic test should be considered as only
one element in the diagnostic algorithm and patient follow-up and drug-response/treatment
success should be taken as the best reference, especially in areas where the HIV prevalence is
high (Apers et al., 2004).
In view of the considerations just raised, it is difficult to ascertain the true accuracy of
the rats as TB detectors. To provide a more accurate index, APOPO is collaborating with the
Swiss Tropical and Public Health Institute and the Ifakara Health Institute on a cohort study
that collects a wide range of diagnostic data, specifically rats’ evaluations, ZN microscopy
results, fluorescent microscopy results, chest X-ray findings, culture analysis, standard PCR
analysis, GeneXpert PCR analysis, patient follow-up evaluations, and drug-response ratings.
This study will also enable us to evaluate the rats’ performance in patients who are and are
not known to be HIV-positive. To date, because permission to know patients’ HIV status
was only recently granted, we have been unable to analyze data separately for HIV-positive
and HIV-negative patients. Doing so is obviously important, because TB is a leading cause
of death in HIV-positive people and it can be especially difficult to diagnose in this
population (Smith et al., 1994; Kivihya-Nduga et al., 2004; Mtei et al., 2005; Cain et al., 2010).
Automated Cage Assessment
Until very recently, all of the TB-detection research was done in manually operated training
cages. With these cages, trainers (typically three for each cage) place the rat in the cage,
observe it as it moves along the line of holes sniffing the sputum samples, record all
identification responses, and reinforce (i.e., delivery of food immediately following)
identification responses to samples known to contain M. tuberculosis. In blinded testing, the
DOTS-centre status of all training samples are known to the trainers, but the status of test
samples are unknown. Although the manually operated cages are workable, as evident in
the data reported by Weetjens et al. (2009a, 2009b), human error is a real and significant
problem with all such systems (Poling et al., 1995).
Despite APOPO’s confidence in its trained and certified rodent trainers, mistakes
occur. For example, appropriately reinforcing correct identification responses requires
trainers to be aware of which pots are known to contain M. tuberculosis, to ascertain when a
rat has paused for five seconds at a sniffing hole immediately above such a pot, and to
deliver mashed bananas as soon as the five-second criterion is met. Each rat evaluates many
samples per day (140 in current second-line screening work, but this number could increase
substantially in other applications) and the location of reinforcement samples (those known
to contain the bacillus) changes each time a new set of 10 samples is presented. Even if
procedures are quite standardized, the possibility of errors related to the location of
reinforcement samples could lead to a failure to reinforce a correct identification or, more
seriously, to reinforce an identification response to a sample that does not contain M.
tuberculosis. Moreover, if trainers know that a given sample is a reinforcement sample, this
may affect how they evaluate the rat’s behaviour (e.g., they may consider a four-second
pause as meeting criterion) or lead them to provide cues (e.g., leaning forward) that come to
control the rat’s behaviour. Such actions are unconscious and almost universal and in no
sense constitute cheating (Poling et al., 1995).
To minimize human error and unintentional cues to the rats, APOPO developed a
fully automated cage. It consists of a rectilinear aluminium and plastic chamber 205-cm long
x 55-cm wide x 55-cm high.  The floor of the chamber contains 10 2.5-cm diameter sniffing
holes spaced equidistantly along the centreline. Pots containing sputum can be placed
immediately below these holes by means of a sliding bar with 10 appropriately spaced holes.
A photocell directs a beam of light immediately below each hole and a detector unit is
activated when the beam is broken, indicating that a rat has placed its nose (or potentially
some other body part) in the sniffing hole. A commercial food dispenser located at one end
of the chamber allows for the delivery of food (three 45-mg Noyes banana-flavoured rat
pellets; P.J. Noyes, Lancaster, NH) and computer-directed equipment presents food
automatically when an indication response (pausing, hence breaking the beam) above a TB-
positive sample occurs. A Tanzanian Ph.D. student is studying the behaviour of the rats
when working in this fully-automated cage and it is anticipated that future TB detection will
be conducted in such cages. APOPO intends to produce an exportable TB-detection
technology with specifiable and repeatable characteristics, and automating that technology
as much as possible is a long step in that direction.
Assessment of Common Bacilli in Sputum and Rats’ Reaction to Them
A series of projects designed to evaluate the bacilli that are commonly found in the sputum
samples evaluated by APOPO’s rats, and the rats’ reaction to those bacilli, were recently
completed by a Tanzanian student as his Ph.D. research at the Max Planck Institute of
Infection Biology (Mgode et al., 2011a, b). In one study, he and his colleagues compared the
diagnostic performance of the TB-detecting rats on cultures of reference M. tuberculosis,
clinical M. tuberculosis, non-tuberculous mycobacteria species (NTM), Nocardia, Rhodococcus,
Streptomyces, Bacillus, Candida, and Saccharomyces species. M. tuberculosis and NTM are
related to Nocardia and Rhodococcus species, which are also acid-fast bacilli and can thereby
be misdiagnosed as M. tuberculosis in smear microscopy. Trained rats distinguished M.
tuberculosis from other microbes (p=0.008, Fisher’s exact test). The detection of naturally TB-
infected sputum exceeded that of negative sputum mixed with pure cultures of M.
tuberculosis, indicating that rats are highly conditioned to detect odours of spiked TB-
positive sputum rather than spiked TB-negative sputum (Mgode et al., 2011a).
Another study compared the odours (volatiles) of microbiota from smear-negative
and M. tuberculosis culture-negative, but rat-positive, sputa to the odours of M. tuberculosis.
Rat-positive sputa containing Streptococcus pneumoniae, Staphylococcus spp. and Enterococcus
spp. were associated with TB-positivity. However, analysis of volatiles from Streptomyces
spp., Candida spp., Rhodococcus spp. and Nocardia spp., representing microbiota from smear-
negative and M. tuberculosis culture-negative but rat-positive sputa revealed that these
microbes do not produce M. tuberculosis-specific volatiles. Furthermore, the prevalence of
mycobacteria-related Nocardia and Rhodococcus spp. is substantially lower than the
percentage of smear-negative sputa detected by rats, of which 44.7% were M. tuberculosis
culture-positive. Therefore, the rats are reacting to M. tuberculosis-specific odour compounds
but not to odours from other respiratory tract microbiota (Mgode et al., 2011b). It is
noteworthy that several volatile compounds characteristic for the TB odour have been
identified and it is clear that TB-specific odour is not due to a single compound but rather to
a combination of different volatiles. This combination is characteristic for M. tuberculosis and
allows discrimination from odours produced by other related pathogenic and apathogenic
microbes of the respiratory tract (Nawrath et al., in press).
Patient Follow-up
Every Friday, a laboratory technician from APOPO visits each partnering DOTS centre to
collect sputum samples and deliver a list of sputum samples that were found TB-negative by
microscopy at that centre but found positive by the rats and confirmed by a second
microscopy (or a GeneXpert analysis) at APOPO. In principle, the patient should be
contacted through the telephone number provided during submission of the sputum
sample, asked to return to the DOTS centre, and given treatment as deemed necessary by
the attending physician. APOPO has reported more than 2,000 additional TB-positive cases
to the DOTS centres, but information about the treatments they received and their response
to these treatments could not be obtained.  Therefore, the actual clinical benefit derived from
the use of rats in second-line screening is unclear.
This issue was the focus of a coordination meeting recently held by APOPO, SUA,
NIMR, and NTLP. Members of these organizations agreed that a sound strategy for
maximizing clinical benefit is obtaining from NTLP accreditation for APOPO’s microscopy
(both bright-field and LED) and GeneXpert (i.e., Xpert MTB/RT) facility as a TB diagnostic in
Tanzania. Following accreditation, APOPO’s laboratory will participate in all official quality
control schemes conducted by NTLP, which will maintain the quality of diagnostic results.
The anticipated outcome of this effort is to have the second microscopy (or automated PCR
analysis) performed at APOPO officially recognized by NTLP, which at the DOTS centres
will prompt immediate patient recall for possible clinical action.
A second strategy to maximize clinical benefit is to employ a postgraduate medical
student to conduct a pilot study on the clinical follow-up of patients identified by APOPO’s
rats. This project will examine the rate of patient recalls, examine the relations between
physicians’ final diagnosis and various diagnostic indicators as available (e.g., rats’
evaluations, clinical features, microscopy results, PCR results, and chest X-rays) and, where
treatment is provided, ascertain the relation to the drug(s) prescribed and the patient’s
response to them. Steps currently are underway to implement both strategies for
maximizing (and measuring) clinical benefit.
Future Prospects
APOPO intends to produce a reliable, fast, and simple alternative to the century-old smear
microscopy for TB diagnosis in developing countries. The achievements so far are
encouraging and the strategies implemented to overcome the challenges presented are
promising. Based on results of all research components currently in progress and that of the
cohort study planned in collaboration with the Swiss Tropical and Public Health Institute
and the Ifakara Health Institute, APOPO may soon start using its detection rats’ technology
for first-line screening of TB in people who live in slums, prisons, and other historically
underserved areas. In the meantime, the existing second-line screening program will be
continued and replicated in Mozambique, which will help to ascertain the practicality and
exportability of APOPO’s TB-detection product. Although unconventional, that product
shows promise and appears to merit further investigation and more widespread adoption in
appropriate settings.
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